Internal Med Medical News about Fatty Liver

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Non-alcoholic fatty liver disease from pathogenesis to management: an update
Obesity Reviews, 11/02/09

Musso G et al. – NAFLD entails an increased cardiometabolic and liver–related risk, the latter regarding almost exclusively non–alcoholic steatohepatitis (NASH), the progressive form of NAFLD. Pathogenetic models encompass altered hepatic lipid partitioning and adipokine action, increased oxidative stress, free fatty acid lipotoxicity. On this basis, lifestyle–, drug– or surgically induced weight loss, insulin sensitizers, antioxidants, lipid–lowering drugs have been evaluated in NAFLD/NASH. Most trials are small, of short duration, nonrandomized, without histological end points, thus limiting assessment of long–term safety and efficacy of proposed treatments. All NAFLD patients should be evaluated for their metabolic, cardiovascular and liver–related risk. Liver biopsy remains the gold standard for staging NAFLD, but non–invasive methods are under intense development. Weight loss through lifestyle intervention is the initial approach, because of established efficacy on NAFLD–associated cardiometabolic abnormalities, and to emerging benefits on necroinflammation and overall disease activity in NASH. Bariatric surgery warrants further evaluation before it can be routinely considered in morbidly obese NASH.

<< Previous
Armodafinil for Treatment of Excessive Sleepiness Associated With...

Next >>
Alterations in Caveolin Expression and Ultrastructure After...

Nonalcoholic fatty liver disease: Quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy
Journal of Digestive Diseases, 10/29/09 Relevance Score: 69%

Synergistic effect of fatty liver and smoking on metabolic syndrome
World Journal of Gastroenterology, 11/17/09 Relevance Score: 68%

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease
Hepatology, 11/04/09 Relevance Score: 68%

Decreased Liver Fatty Acid delta-6 and delta-5 Desaturase Activity in Obese Patients
Obesity, 11/03/09 Relevance Score: 67%

Prevention of I/R injury in fatty livers by ischemic preconditioning is associated with increased mitochondrial tolerance: the key role of ATPsynthase and mitochondrial permeability transition
Transplant International, 10/22/09 Relevance Score: 67%